BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37516854)

  • 21. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.
    Li X; Jiang J; Wu Q; You T; Yang F
    Cancer Gene Ther; 2024 May; ():. PubMed ID: 38714850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer.
    Wang H; Yang W; Qin Q; Yang X; Yang Y; Liu H; Lu W; Gu S; Cao X; Feng D; Zhang Z; He J
    Mol Cancer; 2022 Jul; 21(1):151. PubMed ID: 35864508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway.
    Zhu LL; Shi JJ; Guo YD; Yang C; Wang RL; Li SS; Gan DX; Ma PX; Li JQ; Su HC
    Neoplasma; 2023 Apr; 70(2):272-286. PubMed ID: 37226932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells.
    Schneider D; Chua RL; Molitor N; Hamdan FH; Rettenmeier EM; Prokakis E; Mishra VK; Kari V; Wegwitz F; Johnsen SA; Kosinsky RL
    Clin Epigenetics; 2019 Jul; 11(1):98. PubMed ID: 31266541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
    Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
    Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPHK1 potentiates colorectal cancer progression and metastasis via regulating autophagy mediated by TRAF6-induced ULK1 ubiquitination.
    Chen D; Wu J; Qiu X; Luo S; Huang S; Wei E; Qin M; Huang J; Liu S
    Cancer Gene Ther; 2024 Mar; 31(3):410-419. PubMed ID: 38135696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
    Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
    Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
    Dong Y; Xu W; Qi D; Qu H; Jin Q; Sun M; Wang X; Quan C
    Cell Signal; 2023 Dec; 112():110930. PubMed ID: 37852424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
    Ye Q; Cai W; Zheng Y; Evers BM; She QB
    Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trim58 degrades Dynein and regulates terminal erythropoiesis.
    Thom CS; Traxler EA; Khandros E; Nickas JM; Zhou OY; Lazarus JE; Silva AP; Prabhu D; Yao Y; Aribeana C; Fuchs SY; Mackay JP; Holzbaur EL; Weiss MJ
    Dev Cell; 2014 Sep; 30(6):688-700. PubMed ID: 25241935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z
    Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.